Work with us
Interested in research collaborations, assessing or licensing technology, or commercializing our scientists’ innovations? The Kingston General Health Research Institute (KGHRI) welcomes the participation of partners, collaborators and industry.
From novel approaches in heart disease and cancer surgery to large-scale allergy testing, KGHRI currently has 250 clinician and scientists pursuing over 700 active research projects, including 270 active clinical trials. View our areas of research intensity
Looking for highly skilled graduates? KGHRI students and trainees are mentored by globally renowned researchers in key areas of study relevant to our most pressing health needs. Learn about our students
W.J. Henderson Centre for Patient-Oriented Care [link to a page about the Centre] – opening in September 2017
- 10,000 sq-ft in-hospital, multidisciplinary research environment with capabilities for Phase I/II/III/IV clinical trials and pharmacokinetic studies.
- Shared wet and dry labs, blood/tissue preparation and freezer storage areas, meetings spaces, exam/treatment rooms and overnight stay facilities. KINARM™ and eye-tracking labs offer novel technologies for assessing the effects of disease and traumatic injury on the brain.
- 3D echocardiography, interventional echocardiography, 3D strain, and cardiac CT imaging applications.
- Recognized for research and training in novel methods of heart disease diagnosis and treatment.
- World-leading clinical research methods centre, offering research methodology, project development, implementation and management of multicentre research studies for academia and industry.
- Noted for advancements in areas such as nutritional therapies in the critically ill, improvement in palliative and end-of-life care, and prevention and reduction of ventilator-associated pneumonia.
- State-of-the-art lab features MediGuide Technology, providing real-time, precision 3D imaging of catheters and tools while inside the heart.
- Internationally recognized for research and training in novel approaches for treating cardiac arrhythmia.
- Gold-standard indoor, 140-seat allergen challenge facility for studying effectiveness of anti-allergic medications and drug candidates for allergic rhinitis.
- Services include study design, planning and management, labs and pharmacy services and data collection services.
- 10,000 sq-ft research hub linking medical, surgical and pathology clinicians and scientists in biomedical and molecular sciences, targeting causes and treatments for diseases of the gastrointestinal tract and related conditions.
- Leading-edge molecular biology and tissue culture facility, confocal microscopy, ion imaging / electrophysiology laboratory and “Robogut” lab developing novel treatments for C. difficile.
- Integrated Queen’s-hospital research hub for bone and joint disorders, bringing together clinicians and scientists from medicine, engineering, health sciences and computer science.
- Computer-enhanced surgical suites and specialized labs for connective tissue, bio-simulation, tissue processing, prosthesis design, software development and gait analysis.
- Developing novel diagnostic techniques, new drug therapies, improved repair and reconstruction procedures, and enhanced rehabilitation strategies.
- The world's first robotic system for precisely measuring the effects of brain injury on motor and cognitive function, KINARM is available at all of Kingston Health Sciences Centres’ campus sites.
- Used for research into a wide range of brain injuries and diseases, such as stroke, concussion, cardiac arrest and Parkinson’s disease.
- Focus on understanding the function of multiple organ systems and the factors that work together to limit exercise capacity in health and disease
- State-of-the-art equipment and world-leading, non-invasive techniques enable simultaneous recordings of cardio, pulmonary, and circulatory systems.
- Studies the mechanical, chemical and psychological mechanisms of dyspnea (respiratory discomfort) and activity limitation in patients with cardiorespiratory disease (eg. emphysema, chronic bronchitis, asthma, heart failure, using leading-edge breathing and exercise tests and imaging techniques.
- A leader in the development of best practices for treating Chronic Obstructive Pulmonary Disease (COPD)
- The Tumour Tissue Data Repository (TTDR) was established in 1997 to support Correlative Science, and contains unique disease specific collections which are linked to an associated clinical dataset
For information on research partnerships, please contact Seth Chitayat, Director, Research Partnerships, Faculty of Health Sciences, Queen's University.
For general RI information, please contact Lisa McAvoy, Research Administration Facilitator, at 613-549-6666 x 3344